New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Cellectar Biosciences, Inc. (CLRB) vs Dare Bioscience, Inc. (DARE)
- Cellectar Biosciences, Inc. CLRB 0.80 −9.09%
- Dare Bioscience, Inc. DARE 0.41 −8.89%
Cellectar Biosciences, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Dare Bioscience, Inc. are of similar size ($8.9M and $8.9M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −749.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cellectar Biosciences, Inc. leads on 10 and Dare Bioscience, Inc. on 2.
Valuation
Profitability
| Metric | CLRB | DARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 47.37% | 70.18% |
| Operating margin | 0.00% | (746.14%) | 0.00% |
| Net margin | 0.00% | (749.83%) | 0.00% |
| Free cash flow margin | 0.00% | — | 0.00% |
| Return on equity | (172.99%) | (407.13%) | (51.58%) |
| Return on assets | (116.54%) | (40.05%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack